Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Paracrine-mediated angiogenesis refers to the process by which new blood vessels form from pre-existing vasculature, driven by the secretion of soluble factors (paracrine signals) from one cell type that act on neighboring cells—most notably endothelial cells—to stimulate angiogenic responses. Key mediators include VEGF, HGF, bFGF, Angiopoietins, and Interleukins. This mechanism is central in tissue repair, regeneration, and pathological conditions such as tumor growth. Therapies may use either whole-cell approaches leveraging their secretome/paracrinally active products or purified/recombinant forms/EV-based delivery systems mimicking this natural process.
Inhibition or promotion of angiogenesis via modulation of paracrine signaling
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paracrine-mediated angiogenesis.